Alzheimer Disease Clinical Trial
— PDCOfficial title:
Partners in Dementia Care
| Verified date | August 2014 |
| Source | VA Office of Research and Development |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Federal Government |
| Study type | Interventional |
Background: Partners in Dementia Care (PDC) is a care coordination and support service
intervention for veterans with dementia and their family caregivers, delivered through
partnerships between VA medical centers and local Alzheimer's Association Chapters. PDC was
created from seven years of research and development, and was designed to be a feasible and
practical intervention to integrate health, community, and support services. PDC has a
standardized protocol for care coordination and support services, including guidelines for
care plan assessment, care plan development and implementation, ongoing monitoring, and
reassessment. It also offers a structured training curriculum for providers and an
operations manual for uniform implementation.
Objectives: The primary objective of this investigation is to rigorously test the impact of
PDC on a number of outcomes for veterans with dementia, family caregivers, and health care
providers. Within VA Medical Centers, the focus will be on improving dementia care in
primary care clinics, including geriatrics. Two specific research objectives and
corresponding hypotheses will be addressed: 1. To test the impact of PDC on three categories
of outcomes: psychosocial well-being outcomes (patient and caregiver effects); health care
service use (patient effects only); and health care cost (patient effects only). HI:PDC,
compared to usual care, will improve psychosocial well-being, including depression, health
status, adequacy of care, and quality of care for patients with dementia and their
caregivers. H2:PDC, compared to usual care, will reduce health care service use for patients
with dementia, including hospital admissions, emergency department visits, nursing home
admissions, and physician visits. H3:PDC is preferred to usual care based on
cost-effectiveness and cost-benefit analyses. H4:The PDC intervention will be more effective
in improving psychosocial well-being and reducing health care service use for patients and
caregivers dealing with more severe patient impairment (e.g., cognitive status, functional
status, and level of problem behaviors). 2. To evaluate the impact of PDC on role and
intra-psychic strains caused by dementia and its care (patient and caregiver effects).
H5a:PDC, compared to usual care, will decrease patient role and intra-psychic strain,
including embarrassment about the illness, emotional strain, relationship strain, and social
isolation. H5b:PDC, compared to usual care, will decrease caregiver role and intra-psychic
strain, including role captivity, work care-related strain, relationship strain, emotional
and physical health deterioration, and caregiving efficacy. H6:The PDC intervention will be
more effective in decreasing role and intra-psychic strains for patients and caregivers
dealing with more severe patient impairment (e.g., cognitive status, functional status, and
level of problem behaviors). If effective, the long-term objective is to implement PDC in a
regional, QUERI-like demonstration (Quality Enhancement Research Initiative), involving
30-40 VA medical centers. Additionally, the PDC approach will be adapted for other chronic
conditions (e.g., heart disease, COPD, diabetes).
Methods: The proposed study is a 55-month, controlled trial of Partners in Dementia Care.
The PDC intervention will be implemented in two intervention sites and three comparison
sites that are matched on organizational, provider, and patient characteristics.
Findings: No findings at this time.
| Status | Completed |
| Enrollment | 508 |
| Est. completion date | February 2011 |
| Est. primary completion date | September 2010 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Dementia Diagnosis - veteran - reside outside of a long-term care facility - live within local Alzheimer Association chapter service of Houston, Oklahoma City, Boston, or Providence Exclusion Criteria: - Live in long-term care |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | VA Boston Health Care System, Jamaica Plain | Boston | Massachusetts |
| United States | VA Boston Healthcare System, Brockton Campus | Brockton | Massachusetts |
| United States | Michael E DeBakey VA Medical Center | Houston | Texas |
| United States | Oklahoma City, OK | Oklahoma City | Oklahoma |
| United States | VA Medical Center, Providence | Providence | Rhode Island |
| Lead Sponsor | Collaborator |
|---|---|
| VA Office of Research and Development | Alzheimer's Association, Benjamin Rose Institute |
United States,
Bass DM, Judge KS, Snow AL, Wilson NL, Looman WJ, McCarthy C, Morgan R, Ablorh-Odjidja C, Kunik ME. Negative caregiving effects among caregivers of veterans with dementia. Am J Geriatr Psychiatry. 2012 Mar;20(3):239-47. doi: 10.1097/JGP.0b013e31824108ca. — View Citation
Bass DM, Judge KS, Snow AL, Wilson NL, Morgan R, Looman WJ, McCarthy CA, Maslow K, Moye JA, Randazzo R, Garcia-Maldonado M, Elbein R, Odenheimer G, Kunik ME. Caregiver outcomes of partners in dementia care: effect of a care coordination program for vetera — View Citation
Bass DM, Judge KS, Snow AL, Wilson NL, Morgan RO, Maslow K, Randazzo R, Moye JA, Odenheimer GL, Archambault E, Elbein R, Pirraglia P, Teasdale TA, McCarthy CA, Looman WJ, Kunik ME. A controlled trial of Partners in Dementia Care: veteran outcomes after si — View Citation
Bejjani C, Snow AL, Judge KS, Bass DM, Morgan RO, Wilson N, Walder A, Looman WJ, McCarthy C, Kunik ME. Characteristics of Depressed Caregivers of Veterans With Dementia. Am J Alzheimers Dis Other Demen. 2015 Nov;30(7):672-8. doi: 10.1177/1533317512461555. — View Citation
Bradford A, Upchurch C, Bass D, Judge K, Snow AL, Wilson N, Kunik ME. Knowledge of documented dementia diagnosis and treatment in veterans and their caregivers. Am J Alzheimers Dis Other Demen. 2011 Mar;26(2):127-33. doi: 10.1177/1533317510394648. Epub 20 — View Citation
Judge KS, Bass DM, Snow AL, Wilson NL, Morgan R, Looman WJ, McCarthy C, Kunik ME. Partners in dementia care: a care coordination intervention for individuals with dementia and their family caregivers. Gerontologist. 2011 Apr;51(2):261-72. doi: 10.1093/ger — View Citation
Shrestha S, Judge KS, Wilson NL, Moye JA, Snow AL, Kunik ME. Utilization of legal and financial services of partners in dementia care study. Am J Alzheimers Dis Other Demen. 2011 Mar;26(2):115-20. doi: 10.1177/1533317510394156. Epub 2011 Jan 13. — View Citation
Shub D, Bass DM, Morgan RO, Judge KS, Snow AL, Wilson NL, Walder A, Murry B, Kunik ME. Irritability and social isolation in dementia patients with and without depression. J Geriatr Psychiatry Neurol. 2011 Dec;24(4):229-34. doi: 10.1177/0891988711427039. — View Citation
Steiger-Gallagher K, Bass DM, Judge KS, Snow L, Wilson NL, Morgan RO, Walder A, Kunik ME. Satisfaction with dementia care. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2012 Apr 1; 29(4):33-40.
Weber SR, Pirraglia PA, Kunik ME. Use of services by community-dwelling patients with dementia: a systematic review. Am J Alzheimers Dis Other Demen. 2011 May;26(3):195-204. doi: 10.1177/1533317510392564. Epub 2011 Jan 27. Review. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Psychosocial well-being (patient and caregiver), health care service use (patient only), and health care cost (patient only) | A T1 baseline interview will be conducted upon enrollment in the study. T2 interviews are conducted 6 months after the T1 interview. T3 interviews are conducted 6 months after the T2 interviews. | No | |
| Secondary | Role and intra-psychic strain | A T1 baseline interview will be conducted upon enrollment in the study. T2 interviews are conducted 6 months after the T1 interview. T3 interviews are conducted 6 months after the T2 interviews. | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
| Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
| Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
| Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
| Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
| Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
| Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
| Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
| Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
| Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
| Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
| Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
| Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
| Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
| Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
| Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
| Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
| Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
| Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |